Biotech & Health

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M

Healx, a U.K. startup using AI to discover new drugs for rare diseases, has raised $47 million in a Series C round of funding co-led by Europe’s Atomico and Silicon Valley-based R42. The company also said that it has received regulatory clearance to start Phase 2 clinical trials for a new drug in the U.S. […]

Healx, an AI-enabled drug discovery platform for rare diseases, raises $47M Read More »

AI-powered Regard nabs $61M to find missed illness, boost hospital revenue

People in tech often say that data is the new oil. That phrase, coined by British mathematician Clive Humby, of course implies that data is valuable. Data about a person’s health can also provide meaningful insights and improve outcomes, but only 3% of patient data is currently used by physicians, according to the World Economic

AI-powered Regard nabs $61M to find missed illness, boost hospital revenue Read More »

Seae Ventures acquires Unseen Capital after founder death

Seae Ventures is acquiring Unseen Capital after the death of founder Kayode Owens in 2021. The combined firm will continue to invest in healthcare for minorities and underserved populations. Owens, an investor and entrepreneur, launched Unseen Capital to focus early-stage healthcare companies started by underrepresented founders, in 2020. He raised $30 million but unfortunately died

Seae Ventures acquires Unseen Capital after founder death Read More »

J2 Ventures, focused on military healthcare, grabs $150M for its second fund

J2 Ventures, a firm led mostly by the U.S. military veterans, announced on Thursday that it has raised a $150 million second fund. The Boston-based firm invests in startups whose products are purchased by civilians and the U.S. Department of Defense.   While many emerging VCs are struggling to raise second funds, J2’s latest vehicle is

J2 Ventures, focused on military healthcare, grabs $150M for its second fund Read More »

Robot cats, dogs and birds are being deployed amid an ‘epidemic of loneliness’

In the early 1990s, a researcher at Japan’s National Institute of Advanced Industrial Science and Technology began work on what would become Paro. More than 30 years after its development, the doe-eyed seal pup remains the best-known example of a therapeutic robot for older adults. In 2011, the robot reached the zenith of pop cultural

Robot cats, dogs and birds are being deployed amid an ‘epidemic of loneliness’ Read More »

AI-powered drug development, VW teams up with Rivian, and DEI is ‘bad’

Welcome back to another recap of Equity, TechCrunch’s flagship podcast about the business of startups. This episode is jam-packed with deals, hot topics, and the latest dramaaaaaa in the tech world. If you haven’t listened yet, consider this your spoiler-filled invitation to dive in. Three Deals of the Week Formation Bio’s $372M Raise First up,

AI-powered drug development, VW teams up with Rivian, and DEI is ‘bad’ Read More »

Amazon consolidates Amazon Clinic into the One Medical brand

Amazon is folding its Amazon Clinic telehealth service into its primary care business One Medical, the company announced on Thursday.  The company explained in today’s blog post that, to simplify Amazon’s primary care offering for customers, the service has now been rebranded to Amazon One Medical Pay-per-visit, and now offers more affordable per-visit pricing. Customers

Amazon consolidates Amazon Clinic into the One Medical brand Read More »

Formation Bio raises $372M to boost drug development with AI

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap. Formation announced Wednesday that it raised $372 million in a Series D funding round led by Andreessen Horowitz with participation from drug maker Sanofi, Sequoia,

Formation Bio raises $372M to boost drug development with AI Read More »

Sensi.AI grabs $31M Series B from Insight, Zeev to monitor seniors 24/7

Older adults increasingly want to age in their homes rather than nursing facilities. A study by the AARP (American Association of Retired Persons) found that nearly 90% of people over 65 want to stay in their homes as they grow older. That means there is plenty of work for home care agencies whose staff assist

Sensi.AI grabs $31M Series B from Insight, Zeev to monitor seniors 24/7 Read More »